Glyko announces research grants:
This article was originally published in Clinica
Executive Summary
Glyko Biomedical (US) has been awarded a $60,000 development grant for AZT resistance diagnostics. The award from the Paediatric AIDS Foundation will fund a test for AZT drug resistance in people with AIDS. Glyko also received a Phase I SBIR award worth $67,000 from the National Institutes of Health to expand indications for its lysosomal disease test. The company's urinary carbohydrate analysis test for lysosomal storage disease is currently pending US FDA clearance. Lysosomal storage disorders are among the most commonly inherited metabolic diseases and affect around 30,000 people in the US.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.